{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:01:29Z","timestamp":1766023289979,"version":"3.48.0"},"reference-count":24,"publisher":"e-Century Publishing Corporation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/kert9218","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T06:15:14Z","timestamp":1753942514000},"page":"5371-5384","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and prognostic factors for pulmonary infection complications in elderly patients with acute myeloid leukemia"],"prefix":"10.62347","volume":"17","author":[{"given":"Zengfeng","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","unstructured":"Pelcovits A and Niroula R. Acute myeloid leukemia: a review. R I Med J (2013) 2020; 103: 38-40."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000536152","article-title":"Pathophysiology of acute myeloid leukemia","volume":"147","author":"Wachter","year":"2024","unstructured":"Wachter F and Pikman Y. Pathophysiology of acute myeloid leukemia. Acta Haematol 2024; 147: 229-246.","journal-title":"Acta Haematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.3390\/curroncol29090491","article-title":"Management of acute myeloid leukemia: a review for general practitioners in oncology","volume":"29","author":"Stubbins","year":"2022","unstructured":"Stubbins RJ, Francis A, Kuchenbauer F and Sanford D. Management of acute myeloid leukemia: a review for general practitioners in oncology. Curr Oncol 2022; 29: 6245-6259.","journal-title":"Curr Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3324\/haematol.2019.240747","article-title":"Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia","volume":"106","author":"Burchert","year":"2021","unstructured":"Burchert A. Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia. Haematologica 2021; 106: 664-670.","journal-title":"Haematologica"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s11912-022-01299-9","article-title":"Older patients with acute myeloid leukemia deserve individualized treatment","volume":"24","author":"Leeuw DC","year":"2022","unstructured":"de Leeuw DC, Ossenkoppele GJ and Janssen J. Older patients with acute myeloid leukemia deserve individualized treatment. Curr Oncol Rep 2022; 24: 1387-1400.","journal-title":"Curr Oncol Rep"},{"key":"ref5","unstructured":"Song L, Hu Y, Yang Y and Xu L. Clinical effect of teicoplanin on pulmonary infection after chemotherapy for hematologic malignancies. Am J Transl Res 2022; 14: 7467-7476."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Kreft IC, van de Geer A, Smit ER, van der Zwaan C, van Alphen FPJ, Meijer AB, Nur E, Hoogendijk AJ, Kuijpers TW and van den Biggelaar M. Plasma profiling of acute myeloid leukemia with fever- and infection-related complications during chemotherapy-induced neutropenia. Cancer Rep (Hoboken) 2024; 7: e70024.","DOI":"10.1002\/cnr2.70024"},{"key":"ref7","unstructured":"Gong BF, Lin D, Wei H, Wang Y, Liu BC, Zhou CL, Liu KQ, Wei SN, Zhang GJ, Liu YT, Gong XY, Li Y, Zhao XL, Qiu SW, Gu RX, Mi YC and Wang JX. Primary prophylatic effect of voriconazole against invasive infection of pulmonary aspergillosis during remission-induction chemotherapy for acute myeloid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2018; 26: 1269-1274."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4312117","DOI":"10.1155\/2022\/4312117","article-title":"Prediction of lung infection during palliative chemotherapy of lung cancer based on artificial neural network","volume":"2022","author":"Guo","year":"2022","unstructured":"Guo W, Gao G, Dai J and Sun Q. Prediction of lung infection during palliative chemotherapy of lung cancer based on artificial neural network. Comput Math Methods Med 2022; 2022: 4312117.","journal-title":"Comput Math Methods Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(23)02876-3","article-title":"Inflammation, infection, and cardiovascular risk","volume":"403","author":"GM","year":"2024","unstructured":"Lin GM, Huang WC and Han CL. Inflammation, infection, and cardiovascular risk. Lancet 2024; 403: 1021-1022.","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1186\/s12879-024-09895-9","article-title":"Clinical characteristics and prognostic factors of pulmonary and extrapulmonary cryptococcosis","volume":"24","author":"Tao","year":"2024","unstructured":"Tao Z, Pu Q, Shen Y, Zhang S, Wang C, Hu Z, Jin Y, Zhu X and Weng Y. Clinical characteristics and prognostic factors of pulmonary and extrapulmonary cryptococcosis. BMC Infect Dis 2024; 24: 1018.","journal-title":"BMC Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.2147\/IDR.S422564","article-title":"Establishment and validation of models for the risk of multi-drug resistant bacteria infection and prognosis in elderly patients with pulmonary infection: a multicenter retrospective study","volume":"16","author":"Wang","year":"2023","unstructured":"Wang S, Li J, Dai J, Zhang X, Tang W, Li J, Liu Y, Wu X and Fan X. Establishment and validation of models for the risk of multi-drug resistant bacteria infection and prognosis in elderly patients with pulmonary infection: a multicenter retrospective study. Infect Drug Resist 2023; 16: 6549-6566.","journal-title":"Infect Drug Resist"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.archger.2018.10.005","article-title":"The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and clinical pulmonary infection score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients","volume":"80","author":"Wang","year":"2019","unstructured":"Wang Y, Zhang S, Li L and Xie J. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and clinical pulmonary infection score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients. Arch Gerontol Geriatr 2019; 80: 53-57.","journal-title":"Arch Gerontol Geriatr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.blre.2023.101156","article-title":"Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia","volume":"64","author":"DJ","year":"2024","unstructured":"Chandra DJ, Lachowiez CA and Loghavi S. Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia. Blood Rev 2024; 64: 101156.","journal-title":"Blood Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1080\/10428194.2023.2239407","article-title":"Pulmonary infections in patients with acute myeloid leukemia receiving frontline treatment with hypomethylating agents","volume":"64","author":"MC","year":"2023","unstructured":"Scamuffa MC, Latagliata R, Carmosino I, Di Veroli A, Scalzulli E, Trapè G, Ciotti G, De Angelis G, Tartaglia G, Tarnani M, Breccia M and Girmenia C. Pulmonary infections in patients with acute myeloid leukemia receiving frontline treatment with hypomethylating agents. Leuk Lymphoma 2023; 64: 1840-1846.","journal-title":"Leuk Lymphoma"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Alkan A, Buyukasik Y, Uzun O, Demir AU and Coplu L. Invasive fungal infections in patients with acute leukemia: a retrospective cohort study at a tertiary-care hospital. Medicine (Baltimore) 2024; 103: e39959.","DOI":"10.1097\/MD.0000000000039959"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00432-022-03995-2","article-title":"Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia","volume":"149","author":"Tober","year":"2023","unstructured":"Tober R, Schnetzke U, Fleischmann M, Yomade O, Schrenk K, Hammersen J, Glaser A, Thiede C, Hochhaus A and Scholl S. Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia. J Cancer Res Clin Oncol 2023; 149: 1569-1583.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref17","unstructured":"Zhang XP and Xi YM. Analysis of risk factors for pulmonary infection in patients with acute leukemia after chemotherapy. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2024; 32: 933-939."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Lien MY, Chou CH, Lin CC, Bai LY, Chiu CF, Yeh SP and Ho MW. Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: a retrospective cohort study. PLoS One 2018; 13: e0197851.","DOI":"10.1371\/journal.pone.0197851"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1200\/JCO.20.01739","article-title":"Open-label phase II prospective, randomized, controlled study of romyelocel-L myeloid progenitor cells to reduce infection during induction chemotherapy for acute myeloid leukemia","volume":"39","author":"Desai","year":"2021","unstructured":"Desai PM, Brown J, Gill S, Solh MM, Akard LP, Hsu JW, Ustun C, Andreadis C, Frankfurt O, Foran JM, Lister J, Schiller GJ, Wieduwilt MJ, Pagel JM, Stiff PJ, Liu D, Khan I, Stock W, Kambhampati S, Tallman MS, Morris L, Edwards J, Pusic I, Kantarjian HM, Mamelok R, Wong A, Van Syoc R, Kellerman L, Panuganti S, Mandalam R, Abboud CN and Ravandi F. Open-label phase II prospective, randomized, controlled study of romyelocel-L myeloid progenitor cells to reduce infection during induction chemotherapy for acute myeloid leukemia. J Clin Oncol 2021; 39: 3261-3272.","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.3390\/cancers14112773","article-title":"Diagnostic utility of bronchoalveolar lavage in patients with acute leukemia under broad-spectrum anti-infective treatment","volume":"14","author":"Ghandili","year":"2022","unstructured":"Ghandili S, von Kroge PH, Simon M, Henes FO, Rohde H, Hoffmann A, Lindeman NB, Bokemeyer C, Fiedler W and Modemann F. Diagnostic utility of bronchoalveolar lavage in patients with acute leukemia under broad-spectrum anti-infective treatment. Cancers (Basel) 2022; 14: 2773.","journal-title":"Cancers (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.62438\/tunismed.v102i9.4770","article-title":"Invasive pulmonary aspergillosis in patients with acute leukemia","volume":"102","author":"Kassar","year":"2024","unstructured":"Kassar O, Ben Kahla A, Fakhefakh Y, Feki W, Cheikhrouhou F and Elloumi M. Invasive pulmonary aspergillosis in patients with acute leukemia. Tunis Med 2024; 102: 571-575.","journal-title":"Tunis Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1179\/1607845413Y.0000000103","article-title":"D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine","volume":"19","author":"Kimura","year":"2014","unstructured":"Kimura S, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Yamasaki R, Ashizawa M, Machishima T, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J and Kanda Y. D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine. Hematology 2014; 19: 107-112.","journal-title":"Hematology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.1007\/s00277-024-06069-0","article-title":"Incidence of infection in patients with acute myeloid leukemia receiving high-dose cytarabine consolidation","volume":"103","author":"McClellan","year":"2024","unstructured":"McClellan K, Messina J, Saullo J and Huggins J. Incidence of infection in patients with acute myeloid leukemia receiving high-dose cytarabine consolidation. Ann Hematol 2024; 103: 5351-5358.","journal-title":"Ann Hematol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0162989.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:35Z","timestamp":1766022995000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0162989.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/kert9218","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}